Emerging role of berbamine as an anti-cancer agent in systemic malignancies besides chronic myeloid leukemia

Journal of Zhejiang University: Science B

Volumn 13, Issue 9, 2012, Pages 761-762

  Kapoor, Shailendra ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERBAMINE; CARMOFUR; CYCLIN DEPENDENT KINASE 1; DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRICHOSTATIN A; VASCULOTROPIN;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER CELL; CELL MIGRATION; CHRONIC MYELOID LEUKEMIA; ENZYME INHIBITION; G2 PHASE CELL CYCLE CHECKPOINT; LETTER; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LYMPHOMA; MITOCHONDRIAL MEMBRANE POTENTIAL; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

EID: 84866012117     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1200110     Document Type: Letter

References (10)

1. Cheng, Y.H., Qi, J., Xiong, D.S., Liu, J.W., Qi, S.L., Pan, B., Yang, C.Z., Zhu, H.F., 2006. Reversal of multidrug resistance in drug-resistant human breast cancer cell line MCF-7/ADR by calmodulin antagonist O-(4-ethoxylbutyl)- berbamine. Acta Acad. Med. Sin., 28(2):164-168 (in Chinese).
2. Du, H.P., Shen, J.K., Yang, M., Wang, Y.Q., Yuan, X.Q., Ma, Q.L., Jin, J., 2010. 4-Chlorobenzoyl berbamine induces apoptosis and G2/M cell cycle arrest through the PI3K/Akt and NF-kappaB signal pathway in lymphoma cells. Oncol. Rep., 23(3):709-716.
3. Duan, H., Luan, J., Liu, Q., Yagasaki, K., Zhang, G., 2010. Suppression of human lung cancer cell growth and migration by berbamine. Cytotechnology, 62(4):341-348. [doi:10.1007/s10616-009-9240-x]
4. Liang, Y., Xu, R.Z., Zhang, L., Zhao, X.Y., 2009a. Berbamine, a novel nuclear factor kappaB inhibitor, inhibits growth and induces apoptosis in human myeloma cells. Acta Pharmacol. Sin., 30(12):1659-1665. [doi:10.1038/aps. 2009.167]
5. Liang, Y., Zhao, X.Y., Wei, Y.L., Xu, R.Z., 2009b. Berbamine induces apoptosis of multiple myeloma RPMI 8226 cells by activating GADD45/JNK pathway. J. Zhejiang Univ. (Med. Sci.), 38(5):439-444 (in Chinese).
6. Liang, Y., Qiu, X., Xu, R.Z., Zhao, X.Y., 2011. Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 12(7):568-574. [doi:10. 1631/jzus.B1000230]
7. Liu, R., Zhang, Y., Chen, Y., Qi, J., Ren, S.M., Xushi, M.Y., Yang, C.Z., Zhu, H., Xiong, D.S., 2010. A novel calmodulin antagonist O-(4-ethoxyl-butyl)- berbamine overcomes multidrug resistance in drug-resistant MCF-7/ADR breast carcinoma cells. J. Pharm. Sci., 99(7):3266-3275. [doi:10.1002/jps.22082]
8. Wang, G.Y., Zhang, J.W., Lu, Q.H., Xu, R.Z., Dong, Q.H., 2007. Berbamine induces apoptosis in human hepatoma cell line SMMC7721 by loss in mitochondrial transmembrane potential and caspase activation. J. Zhejiang Univ.-Sci. B, 8(4):248-555. [doi:10.1631/jzus.2007.B0248]
9. Wang, G.Y., Lv, Q.H., Dong, Q., Xu, R.Z., Dong, Q.H., 2009. Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice. J. Asian Nat. Prod. Res., 11(3):219-228. [doi:10.1080/10286020802675076]
10. Wang, S., Liu, Q., Zhang, Y., Liu, K., Yu, P.F., Liu, K., Luan, J.L., Duan, H.Y., Lu, Z.Q., Wang, F.F., et al., 2009. Suppression of growth, migration and invasion of highlymetastatic human breast cancer cells by berbamine and its molecular mechanisms of action. Mol. Cancer, 8(1):81. [doi:10.1186/1476-4598-8- 81]